======= SIN3B ======= == Gene Information == * **Official Symbol**: SIN3B * **Official Name**: SIN3 transcription regulator family member B * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=23309|23309]] * **UniProt**: [[https://www.uniprot.org/uniprot/O75182|O75182]] * **Interactions**: [[https://thebiogrid.org/search.php?search=SIN3B&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20SIN3B|Open PubMed]] * **OMIM**: [[https://omim.org/entry/607777|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Acts as a transcriptional repressor. Interacts with MXI1 to repress MYC responsive genes and antagonize MYC oncogenic activities. Interacts with MAD-MAX heterodimers by binding to MAD. The heterodimer then represses transcription by tethering SIN3B to DNA. Also forms a complex with FOXK1 which represses transcription. With FOXK1, regulates cell cycle progression probably by repressing cell cycle inhibitor genes expression. {ECO:0000250|UniProtKB:Q62141}. |HDAC interact| |PAH| |autosome| |Y chromosome| |X chromosome| |XY body| |Sin3 complex| |histone deacetylase activity| |histone deacetylation| |protein deacetylation| |protein deacylation| |macromolecule deacylation| |chromatin| |transcription corepressor activity| |histone modification| |covalent chromatin modification| |chromatin binding| |regulation of lipid metabolic process| |chromatin organization| |negative regulation of transcription by RNA polymerase II| |chromosome organization| |negative regulation of transcription, DNA-templated| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |negative regulation of RNA metabolic process| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |negative regulation of macromolecule biosynthetic process| |negative regulation of cellular biosynthetic process| |negative regulation of biosynthetic process| |negative regulation of gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp125|GSK461364A 0.005μM R03 exp125]]|-2.65| |[[:results:exp316|Geldanamycin 0.015 to 0.025μM on day4 R07 exp316]]|-2.28| |[[:results:exp391|Pomalidomide 20μM R07 exp391]]|-2.18| |[[:results:exp463|Caffeine 2600μM R08 exp463]]|-2.06| |[[:results:exp272|CHIR-124 0.04μM R06 exp272]]|-2.05| |[[:results:exp513|ONC212 0.15μM R08 exp513]]|1.72| |[[:results:exp448|Ammonium tetrathiomolybdate 10μM R08 exp448]]|1.77| |[[:results:exp515|PU-H71 1μM R08 exp515]]|1.81| |[[:results:exp532|TIC10 10μM R08 exp532]]|1.81| |[[:results:exp435|JQ1 0.8μM R08 exp435]]|1.85| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/25| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 7812 * **Expression level (log2 read counts)**: 6.55 {{:chemogenomics:nalm6 dist.png?nolink |}}